A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury

Abstract

Objective The development of acute kidney injury in patients with sepsis is associated with worse outcomes. Identifying those at risk for septic acute kidney injury could help to inform clinical decision making. We derived and tested a multibiomarker-based model to estimate the risk of septic acute kidney injury in children with septic shock. Design Candidate serum protein septic acute kidney injury biomarkers were identified from previous transcriptomic studies. Model derivation involved measuring these biomarkers in serum samples from 241 subjects with septic shock obtained during the first 24 hours of admission and then using a Classification and Regression Tree approach to estimate the probability of septic acute kidney injury 3 days after the onset of septic shock, defined as at least two-fold increase from baseline serum creatinine. The model was then tested in a separate cohort of 200 subjects. Setting Multiple PICUs in the United States. Interventions None other than standard care. Measurements and Main Results The decision tree included a first-level decision node based on day 1 septic acute kidney injury status and five subsequent biomarker-based decision nodes. The area under the curve for the tree was 0.95 (CI95, 0.91–0.99), with a sensitivity of 93% and a specificity of 88%. The tree was superior to day 1 septic acute kidney injury status alone for estimating day 3 septic acute kidney injury risk. In the test cohort, the tree had an area under the curve of 0.83 (0.72–0.95), with a sensitivity of 85% and a specificity of 77% and was also superior to day 1 septic acute kidney injury status alone for estimating day 3 septic acute kidney injury risk. Conclusions We have derived and tested a model to estimate the risk of septic acute kidney injury on day 3 of septic shock using a novel panel of biomarkers. The model had very good performance in a test cohort and has test characteristics supporting clinical utility and further prospective evaluation.

Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis

“…Thus, clinicians can rely on these biomarkers for predicting AKI even in the presence of nonrenal organ failures. This is a notable advance in comparison with other biomarkers that are available around the world (39–42). …”

Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock

“…OLFM4 serum protein concentration data were extracted from an existing proteomic database generated during the derivation and validation of a panel of biomarkers to estimate the probability of sepis-associated acute kidney injury (20). The serum samples were obtained within the first 24 hours of meeting criteria for septic shock.…”

Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies

“…Using discovery oriented transcriptomics, a gene signature associated with the development of septic AKI was identified (6). From this list of candidate genes, a multi-plex protein assay was developed to estimate the risk of septic AKI using a panel of serum protein biomarkers and Classification and Regression Tree methodology (7). The derived model performed well in validation, thus potentially providing a tool to estimate the risk of a specific form of organ failure associated with sepsis.…”